Invitae Investors

30 investors on Angel Roster list Invitae in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Early Stage Venture and the largest groups are based in the United States, South Korea and China.

Investors are matched on the company name in their portfolio, so companies that share the name Invitae can appear together.

Investors listed
30
With verified email
47%
Most common stage
Early Stage Venture
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 30 Invitae investors

The most complete profiles first. Showing 30 of 30.

  • Jonathan LeffVerified

    Venture Capital, Investor · United States

    SeedSeries BHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 66 more

    Verified email available

  • Sarah BhagatVerified

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Victor TongVerified

    Venture Capital, Private Equity Firm · United States

    Early Stage VentureHealth CareChemicalLife ScienceArtificial Intelligence (AI)

    Portfolio: LevitasBio, ARMO BioSciences, Mammoth Biosciences, Cue and 29 more

    Verified email available

  • Alan ColowickVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Claire ChinVerified

    Venture Capital · China

    Health CareChemicalLife ScienceArtificial Intelligence (AI)

    Portfolio: LevitasBio, ARMO BioSciences, Mammoth Biosciences, Cue and 29 more

    Verified email available

  • Daniel KangVerified

    Investment Bank · South Korea

    AdvertisingHealth CareTelecommunicationsGenetics

    Portfolio: The We Company, Cortex, Dialpad, Domio and 84 more

    Verified email available

  • Edward ChungVerified

    Investment Bank · South Korea

    AdvertisingHealth CareTelecommunicationsGenetics

    Portfolio: The We Company, Cortex, Dialpad, Domio and 84 more

    Verified email available

  • Jason PittsVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Jennifer WilliamsVerified

    Venture Capital, Private Equity Firm · Canada

    Health CareLife ScienceBioinformaticsBiotechnology

    Portfolio: IDbyDNA, EBT Medical, Naurex, Aptinyx and 15 more

    Verified email available

  • Kelly HolmanVerified

    Venture Capital, Private Equity Firm · Canada

    Health CareLife ScienceBioinformaticsBiotechnology

    Portfolio: IDbyDNA, EBT Medical, Naurex, Aptinyx and 15 more

    Verified email available

  • Mike PowellVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Qiang XuVerified

    Venture Capital · China

    Health CareChemicalLife ScienceArtificial Intelligence (AI)

    Portfolio: LevitasBio, ARMO BioSciences, Mammoth Biosciences, Cue and 29 more

    Verified email available

  • Wei XuVerified

    Venture Capital · China

    Health CareChemicalLife ScienceArtificial Intelligence (AI)

    Portfolio: LevitasBio, ARMO BioSciences, Mammoth Biosciences, Cue and 29 more

    Verified email available

  • Dan Zabrowski

    Venture Capital, Private Equity Firm · United States

    Early Stage VentureHealth CareChemicalLife ScienceArtificial Intelligence (AI)

    Portfolio: LevitasBio, ARMO BioSciences, Mammoth Biosciences, Cue and 29 more

    Contact details available

  • Fang Yang

    Venture Capital, Private Equity Firm · China

    Early Stage VentureHealth CareInvestment ManagementChemicalLife Science

    Portfolio: LevitasBio, ARMO BioSciences, Mammoth Biosciences, Cue and 29 more

    Contact details available

  • Maha Katabi, PhD, CFA

    Hedge Fund, Venture Capital, Investor · Canada

    SeedHealth CareGeneticsWomen FoundedInvestment Management

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 64 more

    Contact details available

  • Nick Pliam

    Venture Capital, Private Equity Firm · United States

    Early Stage VentureHealth CareChemicalLife ScienceArtificial Intelligence (AI)

    Portfolio: LevitasBio, ARMO BioSciences, Mammoth Biosciences, Cue and 29 more

    Contact details available

  • Perry Nisen

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

  • Weizhi (Aaron) Li

    Venture Capital, Private Equity Firm · China

    Early Stage VentureHealth CareChemicalLife ScienceArtificial Intelligence (AI)

    Portfolio: LevitasBio, ARMO BioSciences, Mammoth Biosciences, Cue and 29 more

    Contact details available

  • Y. Katherine Xu

    Venture Capital, Private Equity Firm · United States

    Early Stage VentureHealth CareChemicalLife ScienceArtificial Intelligence (AI)

    Portfolio: LevitasBio, ARMO BioSciences, Mammoth Biosciences, Cue and 29 more

    Contact details available

  • Alfred Yue

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

  • Cindy Jin

    Investment Bank · South Korea

    AdvertisingHealth CareTelecommunicationsGenetics

    Portfolio: The We Company, Cortex, Dialpad, Domio and 84 more

    Contact details available

  • Heejae Jung

    Investment Bank · South Korea

    AdvertisingHealth CareTelecommunicationsGenetics

    Portfolio: The We Company, Cortex, Dialpad, Domio and 84 more

    Contact details available

  • Hooman Shahlavi

    Hedge Fund, Venture Capital · United States

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

  • JP Lee

    Investment Bank · South Korea

    AdvertisingHealth CareTelecommunicationsGenetics

    Portfolio: The We Company, Cortex, Dialpad, Domio and 84 more

    Contact details available

  • Jamie Stiff

    Venture Capital, Private Equity Firm · Canada

    Health CareLife ScienceBioinformaticsBiotechnology

    Portfolio: IDbyDNA, EBT Medical, Naurex, Aptinyx and 15 more

    Contact details available

  • Jay Choi

    Investment Bank · South Korea

    AdvertisingHealth CareTelecommunicationsGenetics

    Portfolio: The We Company, Cortex, Dialpad, Domio and 84 more

    Contact details available

  • SJ Baek

    Investment Bank · South Korea

    AdvertisingHealth CareTelecommunicationsGenetics

    Portfolio: The We Company, Cortex, Dialpad, Domio and 84 more

    Contact details available

  • Sean Lee

    Investment Bank · South Korea

    AdvertisingHealth CareTelecommunicationsGenetics

    Portfolio: The We Company, Cortex, Dialpad, Domio and 84 more

    Contact details available

  • Anya SchiessVerified

    Venture Capital, Private Equity Firm, Angel/Individual

    SeedPre-SeedHealth CareHospitalsGeneticsAccounting

    Portfolio: Carta Healthcare, Invitae

    Verified email available

By investment stage

By location

Related industries

Most-backed portfolio companies

Frequently asked questions

How many Invitae investors are on Angel Roster?

Angel Roster lists 30 Invitae investors. 14 of them (47%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (22), Private Equity Firms (10) and Investment Banks (8). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Invitae investors invest in?

Among those that list a stage, the most common are Early Stage Venture (6), Seed (5) and Series B (1).

Where are Invitae investors based?

Most are based in the United States (12), South Korea (8) and China (5).

Which companies have Invitae investors backed?

The most-backed portfolio companies among them are Checkmate Pharmaceuticals (18), VelosBio (18), Athira Pharma (9), Arcus Biosciences (9) and Ziarco (9).

How do I contact Invitae investors?

Create a free Angel Roster account to search and filter all 30, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.